People on the Move: October 2020

By Jenni Spinner

07-Oct-2020 - Last updated on 02-Nov-2020 at 19:57 GMT

( narith_2527/iStock via Getty Images Plus)

The latest news on pharmaceutical industry hires, promotions, acquititions and other events includes Medable, Eversana, Parexel, Astellas and more.

People on the Move: October 2020

Medable: leadership team appointments

Eversana: Alkemy Partners acquisition

CureDuchenne: Duchenne United Gaming event

Adamas Pharmaceuticals: Adrian Quartel, chief medical officer

Parexel: Roam Analytics transaction

ChargePoint Technology: Emma Stoddart, chief financial officer

Covis Group: AMAG Pharmaceuticals acquisition

Boyds: Kathryn Bartley, senior clinical research associate

ProSciento: financing from 1315

Astellas: Patient Centricity leaders

Stevanato Group: US Technology Excellent Center

WCG: Carsten Henke, senior vice president, Europe; managing director, Germany

Sterling Pharma Solutions: API facility acquisition

Raremark: executive hires

Cytel: Laiya Consulting acquisition

Related tags: Medable, Eversana, Rare disease, Parexel, Astellas, Patient centricity, acquisition, Packaging, API

Related news

People on the Move: November 2020

Related products

show more

APAC Region Distribution Considerations for Clinical Trial Supplies

Catalent Pharma Solutions | 19-Oct-2021 | Insight Guide

The Asia-Pacific (APAC) region has been a steadily growing area for sponsors to conduct clinical studies. Maintaining continuity of trial supply across...

LACTIUM®: dairy bioactive to soothe your pet

Ingredia | 12-Oct-2021 | Infographic

Lactium® gives you the chance to better meet your pet’s needs for a more harmonious life together. Lactium® acts on the brain and has no side-effects,...

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Overcoming Solubility Challenges with Liquid-Filled Capsules

Altasciences | 28-Sep-2021 | Technical / White Paper

Poorly soluble molecules comprise more than 70% of the small molecule products entering the drug development pipeline today, and are difficult to formulate...

Related suppliers

Ajinomoto Bio-Pharma Services

Baxter BioPharma Solutions

BioContinuum™ Platform - MilliporeSigma

Frontage Laboratories

Laurus Labs Ltd.

Piramal Pharma Solutions

PRA Health Sciences

Precision for Medicine

Softigel by Procaps

Vetter Pharma International GmbH

Follow us

Products

View more

Webinars

Upcoming editorial webinars

17 Nov 2021 Wed Webinar Patient-centric Solutions

On-demand webinars

Headlines

Promotional Features